One of the candidate oncogenic mechanism of HER2 independently of PI3K/AKT and MAPK is proteolytic cleavage of HER2 and production of p95HER2 fragments which is reported correlated with more aggressiveness and poor prognosis of breast cancer. The gene discussed is AKT1; the disease is breast carcinoma.